Bethesda, MD, United States of America

Matthew J McAuliffe


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Prostate Cancer Detection: The Work of Matthew J. McAuliffe

Introduction: Matthew J. McAuliffe, based in Bethesda, MD, is an inventor known for his groundbreaking contributions to the field of medical imaging and cancer diagnosis. With a significant focus on enhancing prostate cancer detection, his innovations employ advanced computing techniques in medical applications.

Latest Patents: McAuliffe holds a patent titled "Detection of prostate cancer in multi-parametric MRI using random forest with instance weighting and MR prostate segmentation by deep learning with holistically-nested networks." This patent outlines a computer-aided diagnosis (CAD) system that utilizes a Random Forest classifier to identify potential cancer sites within the prostate. The system analyzes individual pixels by extracting a combination of spatial, intensity, and texture features from three MRI sequences. It incorporates instance-level weighting in its training process, ensuring that both small and large cancerous lesions receive equitable attention. Additionally, the patent describes novel methods for accurate automatic segmentation of the prostate in MRI, employing both patch-based and holistic deep learning techniques. These methods also enhance the precision of prostate boundary detection.

Career Highlights: Matthew J. McAuliffe works with the United States Department of Health and Human Services, a role that places him at the forefront of innovative health solutions. His work directly influences the development of tools used in detecting prostate cancer, a common yet often difficult-to-diagnose condition.

Collaborations: McAuliffe collaborates with notable coworkers, including Nathan S. Lay and Yohannes Tsehay. Together, they contribute to the advancement of cancer detection technologies and improve the diagnostic capabilities of medical imaging through innovative research.

Conclusion: Matthew J. McAuliffe's contributions to prostate cancer detection exemplify the intersection of technology and healthcare. His patent reflects significant advancements in the use of machine learning and deep learning for medical diagnostics, underscoring his role as a pivotal inventor in the fight against cancer. Through his collaboration with experts in the field, McAuliffe continues to push the boundaries of innovation, offering hope for better diagnostic solutions in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…